Pharmaceutical Co-crystals
Insight into Concept and Progress on Pharmaceutical Co-Crystals: An overview
... Pharmaceutical co-crystals have conferred significant recognition in recent past as a new solid form by virtue their capability to modulate physicochemical properties of Active Pharmaceutical ...
17
Pharmaceutical Co-Crystals: An Overview on Synthesis and Regulatory Aspects
... The co-crystal engineering is done by following hydrogen bonding rules and molecular structure by using Cambridge structural ...database. co-crystals can be synthesized by solution mediated and solvo ...
6
A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals
... of Pharmaceutical co-crystals, the only criteria that needs to be demonstrated in order to obtain a patent is utility or application of the ...invention. Co-crystals offer opportunities ...
9
NOVEL APPROACH OF PHARMACEUTICAL CO-CRYSTALS FOR POORLY SOLUBLE DRUGS
... X-ray powder diffractometry (XRPD) is a powerful technique for the identification of the crystalline solid phases. Every crystalline solid phase has a unique XRPD pattern, which can form the basis for its ...
10
Engineering and manufacturing of pharmaceutical co-crystals : a review on solvent-free manufacturing technologies
... nicotinamide to form cocrystals to act as a model drug to process using HME technology, with the aim of demonstrating cocrystallization as a useful strategy to avoid thermal degradation during HME. This cocrystal was ...
14
FORMULATION AND EVALUATION OF CO CRYSTALS OF POORLY WATER SOLUBLE DRUG
... (or) Pharmaceutical co-crystals have, however, been defined as ‘co-crystals that are formed between a molecular or ionic active pharmaceutical ingredient (API) and a benign ...
10
Co-crystals: An opportunity for poorly soluble drugs
... Pharmaceutical co-crystals are type of crystals and composed of a drug and one or more solid (at room temperature) co-crystal ...former. Co-former used in process of ...
11
An Overview of Pharmaceutical Co-Crystal
... through pharmaceutical co-crystals draw closer the fields of crystal engineering and pharmaceutical sciences 9,10 ...A pharmaceutical co-crystal is a single crystalline solid ...
8
<p>Co-crystals as a new approach to multimodal analgesia and the treatment of pain</p>
... coformer co-crystal has several potential physicochemical and pharmacokinetic (PK) bene fi ts, compared with the API ...100 co-crystal stu- dies have shown improved solubility and/or dissolution rates, 23 ...
11
Formulation and solid state characterization of nicotinamide-based co-crystals of fenofibrate
... in pharmaceutical industry for drug delivery because of the inherent and thermodynamic stability of crystalline ...years. Pharmaceutical co-crystals can be defined as crystalline materials ...
7
Co-crystals of diflunisal and isomeric pyridinecarboxamides – a thermodynamics and crystal engineering contribution
... active pharmaceutical ingredients, APIs, are concerned 5, 9, 10 . Pharmaceutical co-crystals, combining an API and an acceptable co-former, 11 have the potential for enhancing the ...
23
The case of the colorless crystals
... bromide crystals for the treatment of epilepsy was reported in 1857 by Sir Charles Locock who, I believe, was the physi- cian accoucheur to our own dear ...
6
Reference pricing versus co-payment in the pharmaceutical industry: : price, quality and market coverage
... the co-payment sys- tem relatively to a reference pricing system, this policy ensures higher market coverage and consequently is superior in terms of access to ...and pharmaceutical expenditure is clearly ...
44
Boundary time crystals
... Conclusions - In this work we introduced boundary time crystals. In the same spirit as in the original defini- tion given in [9], in the BTC phase the time-dependent order parameter appears only in a portion of ...
6
From discovery to scale-up: alpha-lipoic acid : nicotinamide co-crystals in a continuous oscillatory baffled crystalliser
... the co-crystallisation process of ALA and NIC in 1:1 IPA-hexane was scaled-up in a 500 mL batch OBC to identify the key parameters required for design of the continuous ...and co-crystal purity whilst ...
30
Ikaite crystals in melting sea ice – implications for CO 2and pH levels in Arctic surface waters
... of crystals were obtained from each ...ikaite crystals dissolve when tem- perature was allowed to increase above 4 ◦ ...single crystals col- lected from the uppermost 0–10 cm ...the crystals ...
8
The Reflection of Electrons From Crystals and the States of Divalent Crystals
... 5 which we might have combined forYo • However, if none of these solutions are rectuired by the succeding approximations t o meet condi tio·n s of finiteness, a's will occur in certain c[r] ...
32
Reference pricing versus co-payment in the pharmaceutical industry : firms' pricing strategies
... We now introduce product vertical differentiation by assuming that one of the drugs has a higher quality relatively to its competitor. Quality can both be in- terpreted as effective or perceived quality. While the Þ rst ...
39
Capability Analysis and use of Acceptance and Control Charts in the 6-Sigma in Pharmaceutical Industries Case Study: Behestan Tolid Pharmaceutical Co
... Tolid pharmaceutical company is located in Kaveh Industrial town, Saveh road, ...private pharmaceutical holding, that is Behfar, has been raised and as the most important mission, its manufacturing under ...
8
GROWTH, CHARACTERIZATION, NLO AND BIOLOGICAL ACTIVITIES OF Co (II) IONS DOPED Mn (II) L HISTIDINE HYDROCHLORIDE MONOHYDRATE CRYSTALS
... of Co(II), in general, is observed only at low temperature because the spin lattice relaxation time is extremely short for Co(II) ions in octahedral ...of Co(II) ...
22